- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01430130
Investigation of a Novel Silicone Dressing to Maximize the Outcomes of Scar Revision Procedures (IMPROVE) (IMPROVE)
Investigation of a Novel Mechanomodulating Polymer to Maximize the Outcomes of Scar Revision Procedures
Study Overview
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
California
-
Palo Alto, California, United States, 94306
- Duet Plastic Surgery
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
The scar to be revised is:
- at least 12 months old
- linear and suitable for revision by excision and direct closure
- appropriate size and location for Neodyne Dressing
The subject:
- age > 18 and < 65 years old
Exclusion Criteria:
- Subjects with a skin disorder that is chronic or currently active.
- Subjects who are involved in ongoing litigation in connection with the scar to be revised.
- Subjects with a history of collagen vascular disease
- Subjects diagnosed with scleroderma
- Subject who currently smokes
- Subjects with known adverse reactions to steri-strip tapes, medical tapes, or adhesives
- Subjects with oozing, dehiscence, non-closed/healed incisions at time of first application.
- Subjects with inability to maintain adequate care of incision.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: All Study Participants
Half of the revised incision was treated with the embrace device.
Half of the revised incision was treated according to the Investigator's standard of care.
Participant served as his/her own control.
|
Adhesive bandage/dressing intended to minimize scar formation.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Visual Analogue Scale (VAS)
Time Frame: 6 months
|
Visual Analogue Scale Scar Score (VAS Scar Score) was defined and validated by Duncan et al 2006[1]. This scale consists of a 10cm line representing scar quality, with 0 representing normal skin and 10 indicating a poor scar. The assessor places a mark along the line to represent the appearance of the scar. This mark is translated into a score by measuring its position on the 10cm line to one decimal place. The independent panel used this to scale the primary outcome. [1] Duncan J, Bond J, Mason T, Ludlow A, Cridland P, O'Kane S and Ferguson M. Visual Analogue Scale Scoring and Ranking: A Suitable and Sensitive Method for Assessing Scar Quality? Plast. Reconstr. Surg. 118: 909, 2006. |
6 months
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Subject and Investigator Satisfaction With the Aesthetic Results
Time Frame: Up to 12 months
|
Up to 12 months
|
Ease of Use
Time Frame: Up to 12 months
|
Up to 12 months
|
Comfort Level Related to Study Device Application, Wear and Removal
Time Frame: Up to 12 weeks
|
Up to 12 weeks
|
Comparison of Scar Smoothness of Treated Side as Compared to the Control Side
Time Frame: Up to 12 months
|
Up to 12 months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Jennifer Weintraub, MD, Duet Plastic Surgery
- Principal Investigator: Angeline Lim, MD, Duet Plastic Surgery
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- CA005
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hypertrophic
-
Mahidol UniversityCompleted
-
Association of Dutch Burn CentresBausch Health Americas, Inc.Unknown
-
Cairo UniversityUnknown
-
Iran University of Medical SciencesRecruitingDry Needling | Scar Tissue | Hypertrophic Scar | Hypertrophic Surgical Scar | Hypertrophic Scar of Upper Arm (Disorder)United States, Iran, Islamic Republic of
-
University of North Carolina, Chapel HillWithdrawn
-
Massachusetts General HospitalWithdrawnHypertrophic ScarsUnited States
-
Mahidol UniversityCompletedHypertrophic Scars | KeloidsThailand
-
PfizerTerminatedHypertrophic Scars Resulting From Prior Breast Scar Revision SurgeryUnited States
-
Fidia Farmaceutici s.p.a.Recruiting
Clinical Trials on embrace device
-
Stanford UniversityCompleted
-
Neodyne Biosciences, Inc.U.S. Army Medical Research and Development CommandCompleted
-
University of California, DavisRecruitingLinear Cutaneous WoundUnited States
-
University of MichiganCompletedDepression | Stress | Anxiety | Trauma, Psychological | Racial DiscriminationUnited States
-
Danish Rehabilitation Centre for Neuromuscular...CompletedCognitive Impairment | Rehabilitation | Relatives | Health Care ProvidersDenmark
-
Taichung Veterans General HospitalRecruiting
-
Centre Hospitalier Universitaire VaudoisTerminated
-
Daniëlle van de GraafComprehensive Cancer Centre The Netherlands; Dutch Cancer SocietyRecruitingChemotherapy-induced Peripheral Neuropathy | Cancer SurvivorsNetherlands
-
Cairo UniversityUnknown